Why would Cohen reach out to Novartis, but not Roche?; WuXi Biologics blueprints big R&D/manufacturing complex
→ So why would Trump attorney Michael Cohen reach out to sell his services to Novartis, but ignore the big Basel rival Roche? “I have asked internally if we had any contact, and that is not the case,” Severin Schwan told Reuters.
→ A booming WuXi Biologics is building a new complex in Shijiazhuang, China that will expand its operations in research, development and manufacturing. Its new manufacturing ops will be built to global cGMP standards. “We are very pleased to establish the largest biologics center in northern China, which will enable local companies to more effectively develop and manufacture biologics and in the meantime provide a robust supply chain network for our global clients. This expansion will allow us great access to local talents, markets and government support,” said Chris Chen, the CEO of WuXi Biologics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.